Immunogenic Issues Concerning Recombinant Adeno-Associated Virus Vectors for Gene Therapy
Journal:
Current Gene Therapy
Volume:
2
Page:
485-500
Author(s):
J. Y. Sun, S. Chatterjee, K. K. Wong and Jr.
Selective Cyclooxygenase-2 Inhibitors and Non-small Cell Lung Cancer
Journal:
Current Medicinal Chemistry
Volume:
9
Page:
1851-1858
Author(s):
C. Gridelli, P. Maione, G. Airoma and A. Rossi
Flavonoids as Anticancer Agents: Structure-Activity Relationship Study
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
2
Page:
691-714
Author(s):
M. Lopez-Lazaro
Diagnostic and Therapeutic Applications of Radiolabeled Somatostatin Analogs: Current Status in an Oncology Center
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
1809-1814
Author(s):
Donald A. Podoloff
Epothilones: A Novel Class of Non-taxane Microtubule-stabilizing Agents
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
1707-1712
Author(s):
Ramin Altaha, Tito Fojo, Eddie Reed and Jame Abraham
Immune Modulation by Ionizing Radiation and its Implications for Cancer Immunotherapy
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
1765-1780
Author(s):
Eric J. Friedman
Improvement of Nonviral Gene Therapy by Epstein-Barr Virus (EBV)-based Plasmid Vectors
Journal:
Current Gene Therapy
Volume:
2
Page:
379-392
Author(s):
O. Mazda
How to Inhibit Telomerase Activity for Cancer Therapy
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
2
Page:
613-626
Author(s):
Satoru Kyo and Masaki Inoue
Rational Design of 5-Aminolevulinic Acid Derivatives Aimed at Improving Photodynamic Therapy
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
2
Page:
465-475
Author(s):
Adriana Casas and Alcira Batlle
Novel Concepts in the Development of Platinum Antitumor Drugs
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
2
Page:
539-551
Author(s):
M. A. Fuertes, J. Castilla, C. Alonso and J. M. Perez